Hang Su
Impact in
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Ferroptosis and cancer prognosis
- Microbiology top 10%
Papers in
-
- Lung Cancer Diagnosis and Treatment 31
- Lung Cancer Treatments and Mutations 24
- Medical Imaging and Pathology Studies 7
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
- Pleural and Pulmonary Diseases 5
-
- Natural product bioactivities and synthesis 3
- Co-authors
- Yijiu Ren (20 shared papers)Chang Chen (21 shared papers)Huikang Xie (23 shared papers)Yunlang She (21 shared papers)Chenyang Dai (19 shared papers)Dong Xie (18 shared papers)Gening Jiang (14 shared papers)Chunyan Wu (18 shared papers)
- Journals
- Therapeutic Advances in Medical Oncology (3 papers)Journal of Thoracic Oncology (2 papers)Modern Pathology (2 papers)Lung Cancer (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Hang Su
51 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 94
- Pulmonary and Respiratory Medicine 640
- Microbiology 9
- Pollution 117
- Industrial and Manufacturing Engineering 83
- Radiology, Nuclear Medicine and Imaging 220
Countries citing papers authored by Hang Su
This map shows the geographic impact of Hang Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hang Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hang Su more than expected).
Fields of papers citing papers by Hang Su
This network shows the impact of papers produced by Hang Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hang Su. The network helps show where Hang Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Hang Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 145 | |
| 2 | 2022 | 124 | |
| 3 | 2021 | 79 | |
| 4 | 2012 | 64 | |
| 5 | 2019 | 53 | |
| 6 | 2017 | 48 | |
| 7 | 2022 | 46 | |
| 8 | 2017 | 40 | |
| 9 | 2018 | 36 | |
| 10 | 2021 | 34 | |
| 11 | 2019 | 33 | |
| 12 | 2020 | 28 | |
| 13 | 2020 | 26 | |
| 14 | 2019 | 24 | |
| 15 | 2020 | 22 | |
| 16 | 2018 | 19 | |
| 17 | 2016 | 18 | |
| 18 | 2018 | 17 | |
| 19 | 2013 | 16 | |
| 20 | 2019 | 16 |
About Hang Su
Hang Su is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 54 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (31 papers), Lung Cancer Treatments and Mutations (24 papers), Medical Imaging and Pathology Studies (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Pleural and Pulmonary Diseases (5 papers), Radiomics and Machine Learning in Medical Imaging (5 papers), Iron-based superconductors research (4 papers) and Natural product bioactivities and synthesis (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (640 citations), Microbiology (9 citations), Pollution (117 citations), Industrial and Manufacturing Engineering (83 citations) and Radiology, Nuclear Medicine and Imaging (220 citations). Hang Su has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yijiu Ren, Chang Chen, Huikang Xie, Yunlang She, Chenyang Dai, Dong Xie, Gening Jiang, Chunyan Wu, Hui Zheng and Erjia Zhu. Their work appears in journals such as Therapeutic Advances in Medical Oncology, Journal of Thoracic Oncology, Modern Pathology, Lung Cancer and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.